Stock FAQs

why is sens stock down

by Hulda Bogisich Published 3 years ago Updated 2 years ago
image

Will senseonics (Sens) stock ever pull back?

Feb 11, 2022 · Senseonics Holdings, Inc. (SENS) declined in the current market after announcing FDA approval of the Eversense E3 CGM System. SENS values at $2.54, losing more than 30.41% compared to yesterday’s closing price. The stock closed at $3.65 at …

Where can I buy SENs shares?

Feb 11, 2022 · Feb. 11, 2022, 10:00 AM. The FDA has approved Senseonics Holdings Inc's (NYSE: SENS) Eversense E3 Continuous Glucose Monitoring (CGM) System. The Eversense E3, including proprietary sacrificial ...

Is Sens a death Cross in the NASDAQ?

Net income was $86.7 million, or $0.19 per share, in the first quarter of 2022 compared to a net loss of $249.5 million, or ($0.68) per share, in the first quarter of 2021. Net income increased by ...

What is senseonics'stock symbol?

Apr 16, 2022 · Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time. finance.yahoo.com - April 26 at 4:49 PM. Form DEF 14A Senseonics Holdings, For: May 26 - StreetInsider.com. streetinsider.com - April 15 at 10:50 PM.

image

Why did SENS stock drop?

Shares of Senseonics Holdings (SENS -5.26%) were sinking 14.3% as of 3:12 p.m. EDT on Thursday. The big drop came after the medical technology company announced the pricing of a public offering of its stock.Jul 18, 2019

Is it good to buy SENS stock?

Senseonics Holdings Inc has a Long-Term Technical rank of 46. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 54% of the market scoring higher. In the Medical Devices industry which is number 111 by this metric, SENS ranks better than 50% of stocks.5 days ago

Why is SENS being shorted?

A short squeeze for Senseonics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SENS, which in turn drives the price of the stock up even further.

Is SENS stock a buy or sell?

$SENS was analyzed by 13 analysts. The buy consensus is at 75%.6 days ago

Will SENS get FDA approval?

Senseonics wins FDA approval for next-generation Eversense 180-day CGM, provides 2022 outlook. Senseonics (NYSE:SENS) announced today that the FDA approved its next-generation continuous glucose monitor system, which lasts up to half a year.Feb 11, 2022

Is SENS FDA approved?

At long last, following a year of Covid delays, Sensonics (SENS) received the FDA's nod of approval for its long-lasting continuous glucose monitoring system (CGM).Feb 14, 2022

What are the most shorted stocks?

Most Shorted Stocks
Symbol SymbolCompany NameFloat Shorted (%)
FUV FUVArcimoto Inc.44.84%
CTRN CTRNCiti Trends Inc.42.84%
BGFV BGFVBig 5 Sporting Goods Corp.42.74%
CWH CWHCamping World Holdings Inc. Cl A42.13%
42 more rows

Is SENS a meme stock?

Keith Speights: Meme stocks are just all the rage these days, so let's jump briefly on that bandwagon. Two super-hyped meme stocks in the healthcare sector right now are Clover Health -- ticker there is CLOV-- and Senseonics Holdings. Ticker there is SENS.Jul 18, 2021

What is the short interest on SENS?

Sign Up for a Forever Free Fintel Account
Short Interestshares
Short Interest Ratio17.11 Days to Cover
Short Interest % Float19.52%
Off-Exchange Short Volume1,094,866 shares - source: FINRA (inc. Dark Pool volume)
Off-Exchange Short Volume Ratio42.30% - source: FINRA (inc. Dark Pool volume)
1 more row

Is SENS a long term hold?

Senseonics is a U.S.-based medical technology company that focuses on the development and marketing of a long-term, implantable, continuous glucose monitoring system (CGM), the company calls Eversense. The system is both removable and rechargeable, while an app for on-demand monitoring is also available for patients.Mar 10, 2022

Is SENS a hold?

We therefore hold a negative evaluation of this stock.

Who is buying SENS stock?

Top 10 Owners of Senseonics Holdings Inc
StockholderStakeShares bought / sold
Geode Capital Management LLC1.45%+353,248
Susquehanna Financial Group LLLP0.99%-163,686
Northern Trust Investments, Inc.(...0.90%+5,382
Citadel Advisors LLC0.67%+2,986,650
6 more rows

Senseonics Media Sentiment

Media Coverage

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

Senseonics (NYSEAMERICAN SENS) News Headlines Today

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

Why The Shorts May Not Get Squeezed With Senseonics

Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.

The Verdict: Wait for the Other Shoe to Drop Before Buying

According to ShortSqueeze.com, more than a quarter of the SENS stock outstanding float ( 26.3%) may still be sold short. Some may see this as a sign the stock, despite the decline of the short-squeeze stocks trend, still has the ability to get pushed higher, as the crowded short side scrambles to cover.

Is Senseonics a buy right now?

Meme stock mania may be over, but a still-strong stock market is helping to keep Senseonics shares at elevated prices. Elevated to a point where the company’s valuation is way above its likely growth potential. At some point (hard to say when), this discrepancy will correct itself.

What stocks does MarketBeat like better than Senseonics?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Senseonics stock.

When is Senseonics' next earnings date?

Wall Street analysts have given Senseonics a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Senseonics wasn't one of them.

How were Senseonics' earnings last quarter?

Senseonics is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.#N#View our earnings forecast for Senseonics.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) issued its quarterly earnings data on Monday, August, 9th. The company reported ($0.42) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.40.

What price target have analysts set for SENS?

Senseonics updated its FY 2021 earnings guidance on Monday, September, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $12 million-$15 million, compared to the consensus revenue estimate of $13.82 million.

Who are some of Senseonics' key competitors?

7 equities research analysts have issued 12 month price targets for Senseonics' shares. Their forecasts range from $1.00 to $6.00. On average, they expect Senseonics' share price to reach $3.30 in the next year.

What is Senseonics Holdings?

Some companies that are related to Senseonics include Mesa Laboratories (MLAB), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Sypris Solutions (SYPR), ClearSign Technologies (CLIR), International Isotopes (INIS), Winland (WELX), Electro-Sensors (ELSE), Schmitt Industries (SMIT), Universal Detection Technology (UNDT), Integral Vision (INVI) and National Automation Services (NESV).#N#View all of SENS's competitors..

What is a CGM system?

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9